ICBLD 2020 : International Conference on Drugs for Blood Disorders is the premier interdisciplinary platform for the presentation of new advances and research results in the fields of Drugs for Blood Disorders. The conference will bring together leading academic scientists, researchers and scholars in the domain of interest from around the world. Topics of interest for submission include, but are not limited to:
-
Leukemia Drugs
Lymphoma DrugsMyeloma DrugsLeukemia DrugsArranon (Nelarabine)Asparaginase Erwinia chrysanthemiHyper-CVADArsenic TrioxideCerubidine (Daunorubicin Hydrochloride)CyclophosphamideAlemtuzumabArzerra (Ofatumumab)Bendamustine HydrochlorideBendeka (Bendamustine Hydrochloride)Lymphoma DrugsDoxorubicinBleomycinVinblastineDacarbazineBleomycinEtoposideDoxorubicinCyclophosphamideVincristineProcarbazineMyeloma Drugs:MelphalanVincristine (Oncovin)Cyclophosphamide (Cytoxan)Etoposide (VP-16)Doxorubicin (Adriamycin)Liposomal doxorubicin (Doxil)Bendamustine (Treanda)